Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089648
Status:
COMPLETED
Last Update Posted:
2010-01-12
First Post:
2004-08-09
Brief Title:
SU011248 In The Treatment Of Patients With Bevacizumab Avastin-Refractory Metastatic Renal Cell Carcinoma
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Carcinoma Renal Cell |
Keywords: